LAURUSLABS.NS Cash Flow
Laurus Labs Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:35
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹993.90 Cr. | ₹665.69 Cr. | ₹601.65 Cr. | ₹1,623.50 Cr. | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-996.06 Cr. | ₹-822.42 Cr. | ₹-681.72 Cr. | ₹-1,088.66 Cr. | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹-26.64 Cr. | ₹249.83 Cr. | ₹39.28 Cr. | ₹-524.72 Cr. | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹-0.88 Cr. | ₹0.17 Cr. | ₹1.39 Cr. | ₹3.00 Cr. | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹-29.68 Cr. | ₹93.27 Cr. | ₹-39.40 Cr. | ₹13.12 Cr. | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹75.35 Cr. | ₹45.67 Cr. | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from LAURUSLABS.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).